0001752724-25-116077.txt : 20250522 0001752724-25-116077.hdr.sgml : 20250522 20250522151336 ACCESSION NUMBER: 0001752724-25-116077 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250522 DATE AS OF CHANGE: 20250522 PERIOD START: 20251231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AB VARIABLE PRODUCTS SERIES FUND, INC. CENTRAL INDEX KEY: 0000825316 ORGANIZATION NAME: EIN: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-05398 FILM NUMBER: 25976575 BUSINESS ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 66 HUDSON BOULEVARD EAST, 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 66 HUDSON BOULEVARD EAST, 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN VARIABLE PRODUCTS SERIES FUND INC DATE OF NAME CHANGE: 19920703 0000825316 S000010435 AB Small Cap Growth Portfolio C000028836 Class A C000028837 Class B NPORT-P 1 primary_doc.xml NPORT-P false 0000825316 XXXXXXXX S000010435 C000028837 C000028836 AB VARIABLE PRODUCTS SERIES FUND, INC. 811-05398 0000825316 549300O75IUIQOS5Q596 ALLIANCEBERNSTEIN LP 66 Hudson Boulevard East NEW YORK 10001 212-969-1000 AB Small Cap Growth Portfolio S000010435 549300PUXK19XEEMD951 2025-12-31 2025-03-31 N 55153911.58 938334.78 54215576.80 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 ACMBS UST Primoris Services Corp 549300UF3OLBJ8D5K349 Primoris Services Corp 74164F103 12615.00000000 NS USD 724227.15000000 1.335828543652 Long EC CORP US N 1 N N N Onestream Inc 254900CRBCHIYDC37W82 Onestream Inc 68278B107 29101.00000000 NS USD 621015.34000000 1.145455562136 Long EC CORP US N 1 N N N AZEK Co Inc/The 5493002LDDDU1RX46815 AZEK Co Inc/The 05478C105 13146.00000000 NS USD 642707.94000000 1.185467310199 Long EC CORP US N 1 N N N Piper Sandler Cos QUQDBTUSOAKFEVMRMF78 Piper Sandler Cos 724078100 3363.00000000 NS USD 832880.58000000 1.536238529883 Long EC CORP US N 1 N N N Champion Homes Inc N/A Champion Homes Inc 830830105 9540.00000000 NS USD 904010.40000000 1.667436654478 Long EC CORP US N 1 N N TWFG Inc N/A TWFG Inc 87318A101 11814.00000000 NS USD 365170.74000000 0.673553177064 Long EC CORP US N 1 N N N Stifel Financial Corp 549300E5F07FE5GHJX84 Stifel Financial Corp 860630102 7332.00000000 NS USD 691114.32000000 1.274752314357 Long EC CORP US N 1 N N N Alkami Technology Inc 254900FCNYU4HNEV9L47 Alkami Technology Inc 01644J108 28681.00000000 NS USD 752876.25000000 1.388671474947 Long EC CORP US N 1 N N N Newamsterdam Pharma Co NV 984500B6549TF6E14D36 Newamsterdam Pharma Co NV 000000000 12997.00000000 NS USD 266048.59000000 0.490723525789 Long EC CORP NL N 1 N N Rush Street Interactive Inc N/A Rush Street Interactive Inc 782011100 60492.00000000 NS USD 648474.24000000 1.196103183393 Long EC CORP US N 1 N N N Workiva Inc 529900RTOQ8GRWHY1O58 Workiva Inc 98139A105 7369.00000000 NS USD 559380.79000000 1.031771352472 Long EC CORP US N 1 N N N BrightSpring Health Services Inc N/A BrightSpring Health Services Inc 10950A106 26004.00000000 NS USD 470412.36000000 0.867670119484 Long EC CORP US N 1 N N N Repligen Corp 54930006QJ0T5AUO1E71 Repligen Corp 759916109 5111.00000000 NS USD 650323.64000000 1.199514380155 Long EC CORP US N 1 N N N Beta Bionics Inc N/A Beta Bionics Inc 08659B102 10859.00000000 NS USD 132914.16000000 0.245158620169 Long EC CORP US N 1 N N N Semtech Corp 549300J7WUY317SW6O61 Semtech Corp 816850101 16946.00000000 NS USD 582942.40000000 1.075230467713 Long EC CORP US N 1 N N N Merus NV 549300W8GPUWU8QNU293 Merus NV 000000000 6911.00000000 NS USD 290883.99000000 0.536532131850 Long EC CORP NL N 1 N N N AtriCure Inc N/A AtriCure Inc 04963C209 20890.00000000 NS USD 673911.40000000 1.243021728766 Long EC CORP US N 1 N N N Permian Resources Corp 529900NXUJPOKU7OJ511 Permian Resources Corp 71424F105 2639.00000000 NS USD 36550.15000000 0.067416326003 Long EC CORP US N 1 N N N MACOM Technology Solutions Holdings Inc N/A MACOM Technology Solutions Holdings Inc 55405Y100 7342.00000000 NS USD 736989.96000000 1.359369398058 Long EC CORP US N 1 N N N JFrog Ltd N/A JFrog Ltd 000000000 20960.00000000 NS USD 670720.00000000 1.237135228634 Long EC CORP IL N 1 N N N Ollie's Bargain Outlet Holdings Inc 529900YO5DSQCPEFDZ05 Ollie's Bargain Outlet Holdings Inc 681116109 7908.00000000 NS USD 920174.88000000 1.697251849582 Long EC CORP US N 1 N N Upstream Bio Inc N/A Upstream Bio Inc 91678A107 9153.00000000 NS USD 56016.36000000 0.103321523640 Long EC CORP US N 1 N N N Viridian Therapeutics Inc 549300C775BNYF550E70 Viridian Therapeutics Inc 92790C104 18050.00000000 NS USD 243314.00000000 0.448789839306 Long EC CORP US N 1 N N N Intapp Inc N/A Intapp Inc 45827U109 17206.00000000 NS USD 1004486.28000000 1.852763244972 Long EC CORP US N 1 N N N Modine Manufacturing Co Z35SZFYJR8GZZRSIUU09 Modine Manufacturing Co 607828100 8487.00000000 NS USD 651377.25000000 1.201457751529 Long EC CORP US N 1 N N Leonardo DRS Inc 549300HMMEWVG3PPQU18 Leonardo DRS Inc 52661A108 25306.00000000 NS USD 832061.28000000 1.534727340574 Long EC CORP US N 1 N N N Dutch Bros Inc N/A Dutch Bros Inc 26701L100 10140.00000000 NS USD 626043.60000000 1.154730129146 Long EC CORP US N 1 N N N Ascendis Pharma A/S 549300B66JN3W3J8GH73 Ascendis Pharma A/S 04351P101 2281.00000000 NS USD 355516.66000000 0.655746338937 Long EC CORP DK N 1 N N N Halozyme Therapeutics Inc 529900242I3SV9AGM753 Halozyme Therapeutics Inc 40637H109 11782.00000000 NS USD 751809.42000000 1.386703719437 Long EC CORP US N 1 N N N Knife River Corp N/A Knife River Corp 498894104 10473.00000000 NS USD 944769.33000000 1.742616026174 Long EC CORP US N 1 N N Boot Barn Holdings Inc 529900QE1BFMYA3N4E71 Boot Barn Holdings Inc 099406100 7296.00000000 NS USD 783809.28000000 1.445727088529 Long EC CORP US N 1 N N Maze Therapeutics Inc N/A Maze Therapeutics Inc 578784100 10479.00000000 NS USD 115373.79000000 0.212805611984 Long EC CORP US N 1 N N Armstrong World Industries Inc KXMRXXOJ88Q45Y45MG74 Armstrong World Industries Inc 04247X102 5318.00000000 NS USD 749199.84000000 1.381890379519 Long EC CORP US N 1 N N N Chefs' Warehouse Inc/The 549300JYEDC8C547E980 Chefs' Warehouse Inc/The 163086101 10615.00000000 NS USD 578092.90000000 1.066285621441 Long EC CORP US N 1 N N Cullinan Therapeutics Inc N/A Cullinan Therapeutics Inc 230031106 14940.00000000 NS USD 113095.80000000 0.208603885959 Long EC CORP US N 1 N N N Viking Therapeutics Inc 529900IVC72YPFA25M37 Viking Therapeutics Inc 92686J106 4324.00000000 NS USD 104424.60000000 0.192609958546 Long EC CORP US N 1 N N N Houlihan Lokey Inc 549300S3CNGTQ1QZVY46 Houlihan Lokey Inc 441593100 4263.00000000 NS USD 688474.50000000 1.269883197110 Long EC CORP US N 1 N N N Standardaero Inc N/A Standardaero Inc 85423L103 24490.00000000 NS USD 652413.60000000 1.203369287034 Long EC CORP US N 1 N N Monday.com Ltd 984500MDAFVD86E3B328 Monday.com Ltd 000000000 2557.00000000 NS USD 621760.12000000 1.146829300172 Long EC CORP IL N 1 N N N Wingstop Inc 549300SSH3F8HPIM3Q47 Wingstop Inc 974155103 1872.00000000 NS USD 422285.76000000 0.778901166278 Long EC CORP US N 1 N N N Rubrik Inc 254900TRGK2WTBYMYU27 Rubrik Inc 781154109 10251.00000000 NS USD 625105.98000000 1.153000699975 Long EC CORP US N 1 N N N Dianthus Therapeutics Inc 549300Z3N6ODPCOFC890 Dianthus Therapeutics Inc 252828108 8949.00000000 NS USD 162334.86000000 0.299424758679 Long EC CORP US N 1 N N N Denali Therapeutics Inc 549300ZTQ2HO18L3Q830 Denali Therapeutics Inc 24823R105 17793.00000000 NS USD 241895.84000000 0.446174059703 Long EC CORP US N 1 N N N Universal Display Corp N/A Universal Display Corp 91347P105 427.00000000 NS USD 59557.96000000 0.109853963593 Long EC CORP US N 1 N N N ServiceTitan Inc N/A ServiceTitan Inc 81764X103 3400.00000000 NS USD 323374.00000000 0.596459576908 Long EC CORP US N 1 N N N MoonLake Immunotherapeutics N/A MoonLake Immunotherapeutics 61559X104 5596.00000000 NS USD 218635.72000000 0.403271039256 Long EC CORP KY N 1 N N N Akero Therapeutics Inc 549300SI3KG74LBE2955 Akero Therapeutics Inc 00973Y108 6678.00000000 NS USD 270325.44000000 0.498612125805 Long EC CORP US N 1 N N N Titan America SA 9845007APCB6462D6C46 Titan America SA 000000000 24816.00000000 NS USD 335512.32000000 0.618848566783 Long EC CORP BE N 1 N N N Tempus AI Inc N/A Tempus AI Inc 88023B103 3769.00000000 NS USD 181816.56000000 0.335358527440 Long EC CORP US N 1 N N Shift4 Payments Inc N/A Shift4 Payments Inc 82452J109 5893.00000000 NS USD 481517.03000000 0.888152553972 Long EC CORP US N 1 N N RLI Corp 529900AMTJE5ECN9PS55 RLI Corp 749607107 8303.00000000 NS USD 666979.99000000 1.230236823746 Long EC CORP US N 1 N N N GeneDx Holdings Corp N/A GeneDx Holdings Corp 81663L200 4118.00000000 NS USD 364710.67000000 0.672704583307 Long EC CORP US N 1 N N N Kirby Corp I7NO6FZO5GUCG585T325 Kirby Corp 497266106 6960.00000000 NS USD 703029.60000000 1.296729909548 Long EC CORP US N 1 N N N Construction Partners Inc 549300MHLFL4E8JLZU44 Construction Partners Inc 21044C107 11649.00000000 NS USD 837213.63000000 1.544230790144 Long EC CORP US N 1 N N Texas Roadhouse Inc 5299002Y1CNRPDGXTQ75 Texas Roadhouse Inc 882681109 3654.00000000 NS USD 608866.02000000 1.123046282890 Long EC CORP US N 1 N N N SPX Technologies Inc P761FCI0CPOG24I8JE10 SPX Technologies Inc 78473E103 6163.00000000 NS USD 793671.14000000 1.463917174445 Long EC CORP US N 1 N N N AeroVironment Inc 529900PGHVI29YLZ6221 AeroVironment Inc 008073108 4058.00000000 NS USD 483673.02000000 0.892129252418 Long EC CORP US N 1 N N N Vaxcyte Inc 254900M7NMHTGASX8D95 Vaxcyte Inc 92243G108 9764.00000000 NS USD 368688.64000000 0.680041902643 Long EC CORP US N 1 N N N Blueprint Medicines Corp 5299004CC60O9T5HVM83 Blueprint Medicines Corp 09627Y109 6555.00000000 NS USD 580183.05000000 1.070140878774 Long EC CORP US N 1 N N N Bridgebio Pharma Inc 54930028YG89VTY2J114 Bridgebio Pharma Inc 10806X102 14902.00000000 NS USD 515162.14000000 0.950210567528 Long EC CORP US N 1 N N TechnipFMC PLC 549300D5I93QWCJTCK36 TechnipFMC PLC 000000000 4301.00000000 NS USD 136298.69000000 0.251401346337 Long EC CORP GB N 1 N N N Xenon Pharmaceuticals Inc 549300XV44Q9Z1MIPQ03 Xenon Pharmaceuticals Inc 98420N105 7590.00000000 NS USD 254644.50000000 0.469688814599 Long EC CORP CA N 1 N N N Curtiss-Wright Corp TEL51ETZWP7D0ZM4X325 Curtiss-Wright Corp 231561101 2183.00000000 NS USD 692600.41000000 1.277493390054 Long EC CORP US N 1 N N N Korro Bio Inc N/A Korro Bio Inc 500946108 6150.00000000 NS USD 107071.50000000 0.197492134769 Long EC CORP US N 1 N N Fabrinet 5493004TETZ6IYF7CV44 Fabrinet 000000000 2176.00000000 NS USD 429781.76000000 0.792727450978 Long EC CORP KY N 1 N N N Credo Technology Group Holding Ltd N/A Credo Technology Group Holding Ltd 000000000 13910.00000000 NS USD 558625.60000000 1.030378413312 Long EC CORP KY N 1 N N N Rapport Therapeutics Inc N/A Rapport Therapeutics Inc 75383L102 9928.00000000 NS USD 99577.84000000 0.183670166172 Long EC CORP US N 1 N N Flowco Holdings Inc N/A Flowco Holdings Inc 342909108 7749.00000000 NS USD 198761.85000000 0.366613917496 Long EC CORP US N 1 N N N ITT Inc 549300KDSERHTJOXUS80 ITT Inc 45073V108 5341.00000000 NS USD 689843.56000000 1.272408412336 Long EC CORP US N 1 N N N ArcBest Corp 5493006S3KBNE8ZS3J23 ArcBest Corp 03937C105 8524.00000000 NS USD 601623.92000000 1.109688313783 Long EC CORP US N 1 N N N Apogee Therapeutics Inc N/A Apogee Therapeutics Inc 03770N101 7394.00000000 NS USD 276239.84000000 0.509521167724 Long EC CORP US N 1 N N Braze Inc 9845007B9EDBFD37C277 Braze Inc 10576N102 16705.00000000 NS USD 602716.40000000 1.111703380420 Long EC CORP US N 1 N N N Esab Corp 549300ZNV0SWBXEIWT04 Esab Corp 29605J106 6061.00000000 NS USD 706106.50000000 1.302405215764 Long EC CORP US N 1 N N N Legend Biotech Corp 254900EIUFZTW136H859 Legend Biotech Corp 52490G102 8595.00000000 NS USD 291628.35000000 0.537905095201 Long EC CORP KY N 1 N N Novanta Inc N/A Novanta Inc 67000B104 4902.00000000 NS USD 626818.74000000 1.156159865848 Long EC CORP CA N 1 N N N ACV Auctions Inc N/A ACV Auctions Inc 00091G104 55218.00000000 NS USD 778021.62000000 1.435051817063 Long EC CORP US N 1 N N N Palomar Holdings Inc 549300DOI1MUW11BLX74 Palomar Holdings Inc 69753M105 663.00000000 NS USD 90884.04000000 0.167634553322 Long EC CORP US N 1 N N N Alliance Bernstein 5493006YWHO7MNK2U579 AB Fixed Income Shares, Inc. - Government Money Market Portfolio 018616748 734613.00000000 NS USD 734613.00000000 1.354985123020 Long STIV RF US N 1 N N Kestra Medical Technologies Ltd N/A Kestra Medical Technologies Ltd 000000000 12212.00000000 NS USD 304323.04000000 0.561320303060 Long EC CORP US N 1 N N N Ultragenyx Pharmaceutical Inc 529900EV44GVDN1DCX77 Ultragenyx Pharmaceutical Inc 90400D108 5641.00000000 NS USD 204260.61000000 0.376756316276 Long EC CORP US N 1 N N N Insmed Inc 529900Q55QAG41CCAC11 Insmed Inc 457669307 13241.00000000 NS USD 1010155.89000000 1.863220774587 Long EC CORP US N 1 N N N Clearwater Analytics Holdings Inc N/A Clearwater Analytics Holdings Inc 185123106 36021.00000000 NS USD 965362.80000000 1.780600441753 Long EC CORP US N 1 N N N RH 5493008MTS3OGGMHGK69 RH 74967X103 1872.00000000 NS USD 438815.52000000 0.809390116089 Long EC CORP US N 1 N N Portillo's Inc N/A Portillo's Inc 73642K106 49115.00000000 NS USD 583977.35000000 1.077139420934 Long EC CORP US N 1 N N Five Below Inc 529900AAXP5Z6BGI7418 Five Below Inc 33829M101 6457.00000000 NS USD 483790.73000000 0.892346367142 Long EC CORP US N 1 N N N Masimo Corp 549300Q4A8JK0PIYCU29 Masimo Corp 574795100 4357.00000000 NS USD 725876.20000000 1.338870197171 Long EC CORP US N 1 N N SiTime Corp N/A SiTime Corp 82982T106 4226.00000000 NS USD 646028.62000000 1.191592265785 Long EC CORP US N 1 N N N NCR Atleos Corp N/A NCR Atleos Corp 63001N106 25913.00000000 NS USD 683584.94000000 1.260864460635 Long EC CORP US N 1 N N N CG oncology Inc N/A CG oncology Inc 156944100 10740.00000000 NS USD 263022.60000000 0.485142122475 Long EC CORP US N 1 N N N Cytokinetics Inc 549300BE5DY1HW7IHA64 Cytokinetics Inc 23282W605 7389.00000000 NS USD 296963.91000000 0.547746473482 Long EC CORP US N 1 N N Glaukos Corp 5299004JA1LHE21M6T14 Glaukos Corp 377322102 7471.00000000 NS USD 735295.82000000 1.356244576558 Long EC CORP US N 1 N N N Metsera Inc N/A Metsera Inc 59267L107 6704.00000000 NS USD 182482.88000000 0.336587546920 Long EC CORP US N 1 N N Klaviyo Inc N/A Klaviyo Inc 49845K101 22710.00000000 NS USD 687204.60000000 1.267540881350 Long EC CORP US N 1 N N N Celsius Holdings Inc N/A Celsius Holdings Inc 15118V207 12633.00000000 NS USD 449987.46000000 0.829996629308 Long EC CORP US N 1 N N N Everus Construction Group Inc N/A Everus Construction Group Inc 300426103 12696.00000000 NS USD 470894.64000000 0.868559679328 Long EC CORP US N 1 N N StepStone Group Inc N/A StepStone Group Inc 85914M107 14173.00000000 NS USD 740255.79000000 1.365393183458 Long EC CORP US N 1 N N N PROCEPT BioRobotics Corp N/A PROCEPT BioRobotics Corp 74276L105 12269.00000000 NS USD 714791.94000000 1.318425408691 Long EC CORP US N 1 N N N SharkNinja Inc N/A SharkNinja Inc 000000000 2599.00000000 NS USD 216782.59000000 0.399852962553 Long EC CORP KY N 1 N N N FTI Consulting Inc 549300K17GM8EQD0FQ48 FTI Consulting Inc 302941109 3110.00000000 NS USD 510288.80000000 0.941221748654 Long EC CORP US N 1 N N N Alliance Bernstein 5493006YWHO7MNK2U579 AB Fixed Income Shares, Inc. - Government Money Market Portfolio 018616748 818849.40000000 NS USD 818849.40000000 1.510358181783 Long STIV RF US N 1 N N N ARS Pharmaceuticals Inc N/A ARS Pharmaceuticals Inc 82835W108 22620.00000000 NS USD 284559.60000000 0.524866868150 Long EC CORP US N 1 N N Onto Innovation Inc 254900RXZVN73CHOO062 Onto Innovation Inc 683344105 2612.00000000 NS USD 316940.08000000 0.584592286399 Long EC CORP US N 1 N N N Loar Holdings Inc N/A Loar Holdings Inc 53947R105 7756.00000000 NS USD 547961.40000000 1.010708420610 Long EC CORP US N 1 N N N Element Solutions Inc 549300FLGN6P5CU20J91 Element Solutions Inc 28618M106 28608.00000000 NS USD 646826.88000000 1.193064647059 Long EC CORP US N 1 N N N BellRing Brands Inc 549300S3BOK5CMTS8054 BellRing Brands Inc 07831C103 12257.00000000 NS USD 912656.22000000 1.683383768776 Long EC CORP US N 1 N N N CSW Industrials Inc 549300SYOEO3RVQ7FB83 CSW Industrials Inc 126402106 2517.00000000 NS USD 733755.84000000 1.353404101383 Long EC CORP US N 1 N N Karman Holdings Inc N/A Karman Holdings Inc 485924104 11515.00000000 NS USD 384831.30000000 0.709816851012 Long EC CORP US N 1 N N N 2025-04-28 AB VARIABLE PRODUCTS SERIES FUND, INC. Stephen Woetzel Stephen Woetzel Controller XXXX NPORT-EX 2 NPORT_64VS_50484737_0325.htm HTML

AB Variable Products Series Fund, Inc.

AB Small Cap Growth Portfolio

Portfolio of Investments

March 31, 2025 (unaudited)

 

Company    Shares        U.S. $ Value  

COMMON STOCKS – 98.6%

 

Health Care – 23.6%

 

Biotechnology – 14.2%

 

Akero Therapeutics, Inc.(a)

     6,678        $ 270,325  

Apogee Therapeutics, Inc.(a) (b)

     7,394          276,240  

ARS Pharmaceuticals, Inc.(a) (b)

     22,620          284,560  

Ascendis Pharma A/S (ADR)(a)

     2,281          355,517  

Blueprint Medicines Corp.(a)

     6,555          580,183  

Bridgebio Pharma, Inc.(a) (b)

     14,902          515,162  

CG oncology, Inc.(a)

     10,740          263,023  

Cullinan Therapeutics, Inc.(a)

     14,940          113,096  

Cytokinetics, Inc.(a) (b)

     7,389          296,964  

Denali Therapeutics, Inc.(a)

     17,793          241,896  

Dianthus Therapeutics, Inc.(a)

     8,949          162,335  

Halozyme Therapeutics, Inc.(a)

     11,782          751,809  

Insmed, Inc.(a)

     13,241          1,010,156  

Korro Bio, Inc.(a) (b)

     6,150          107,071  

Legend Biotech Corp. (ADR)(a) (b)

     8,595          291,628  

Merus NV(a)

     6,911          290,884  

Metsera, Inc.(a) (b)

     6,704          182,483  

MoonLake Immunotherapeutics(a)

     5,596          218,636  

Newamsterdam Pharma Co. NV(a) (b)

     12,997          266,048  

Ultragenyx Pharmaceutical, Inc.(a)

     5,641          204,261  

Upstream Bio, Inc.(a)

     9,153          56,016  

Vaxcyte, Inc.(a)

     9,764          368,689  

Viking Therapeutics, Inc.(a)

     4,324          104,425  

Viridian Therapeutics, Inc.(a)

     18,050          243,314  

Xenon Pharmaceuticals, Inc.(a)

     7,590          254,644  
       

 

 

 
            7,709,365  
       

 

 

 

Health Care Equipment & Supplies – 4.9%

 

AtriCure, Inc.(a)

     20,890          673,911  

Beta Bionics, Inc.(a)

     10,859          132,914  

Glaukos Corp.(a)

     7,471          735,296  

Kestra Medical Technologies Ltd.(a)

     12,212          304,323  

Masimo Corp.(a) (b)

     4,357          725,876  

Maze Therapeutics, Inc.(a) (b)

     10,479          115,374  
       

 

 

 
          2,687,694  
       

 

 

 

Health Care Providers & Services – 2.8%

 

BrightSpring Health Services, Inc.(a)

     26,004          470,412  

GeneDx Holdings Corp.(a)

     4,118          364,711  

PROCEPT BioRobotics Corp.(a)

     12,269          714,792  
       

 

 

 
          1,549,915  
       

 

 

 

Life Sciences Tools & Services – 1.5%

 

Repligen Corp.(a)

     5,111          650,324  

Tempus AI, Inc.(a) (b)

     3,769          181,816  
       

 

 

 
          832,140  
       

 

 

 

 

1


Company    Shares        U.S. $ Value  

Pharmaceuticals – 0.2%

 

Rapport Therapeutics, Inc.(a) (b)

     9,928        $ 99,578  
       

 

 

 
          12,878,692  
       

 

 

 

Industrials – 23.3%

 

Aerospace & Defense – 6.6%

 

AeroVironment, Inc.(a)

     4,058          483,673  

Curtiss-Wright Corp.

     2,183          692,601  

Karman Holdings, Inc.(a)

     11,515          384,831  

Leonardo DRS, Inc.

     25,306          832,061  

Loar Holdings, Inc.(a)

     7,756          547,961  

Standardaero, Inc.(a) (b)

     24,490          652,414  
       

 

 

 
            3,593,541  
       

 

 

 

Building Products – 5.7%

 

Armstrong World Industries, Inc.

     5,318          749,200  

AZEK Co., Inc. (The)(a)

     13,146          642,708  

CSW Industrials, Inc.(b)

     2,517          733,756  

Knife River Corp.(a) (b)

     10,473          944,769  
       

 

 

 
          3,070,433  
       

 

 

 

Construction & Engineering – 3.7%

 

Construction Partners, Inc. - Class A(a) (b)

     11,649          837,213  

Everus Construction Group, Inc.(a) (b)

     12,696          470,895  

Primoris Services Corp.

     12,615          724,227  
       

 

 

 
          2,032,335  
       

 

 

 

Ground Transportation – 1.1%

 

ArcBest Corp.

     8,524          601,624  
       

 

 

 

Machinery – 4.0%

 

Esab Corp.

     6,061          706,106  

ITT, Inc.

     5,341          689,844  

SPX Technologies, Inc.(a)

     6,163          793,671  
       

 

 

 
          2,189,621  
       

 

 

 

Marine Transportation – 1.3%

 

Kirby Corp.(a)

     6,960          703,030  
       

 

 

 

Professional Services – 0.9%

 

FTI Consulting, Inc.(a)

     3,110          510,289  
       

 

 

 
          12,700,873  
       

 

 

 

Information Technology – 22.3%

 

Electronic Equipment, Instruments & Components – 1.9%

 

Fabrinet(a)

     2,059          406,673  

Novanta, Inc.(a)

     4,902          626,819  
       

 

 

 
          1,033,492  
       

 

 

 

Semiconductors & Semiconductor Equipment – 5.4%

 

Credo Technology Group Holding Ltd.(a)

     13,910          558,626  

MACOM Technology Solutions Holdings, Inc.(a)

     7,342          736,990  

Onto Innovation, Inc.(a)

     2,612          316,940  

 

2


Company    Shares        U.S. $ Value  

Semtech Corp.(a)

     16,946        $ 582,942  

SiTime Corp.(a)

     4,281          654,436  

Universal Display Corp.

     427          59,558  
       

 

 

 
          2,909,492  
       

 

 

 

Software – 13.6%

 

Alkami Technology, Inc.(a)

     28,681          752,876  

Braze, Inc. - Class A(a)

     16,705          602,717  

Clearwater Analytics Holdings, Inc. - Class A(a)

     36,021          965,363  

Intapp, Inc.(a)

     17,206          1,004,486  

JFrog Ltd.(a)

     20,960          670,720  

Klaviyo, Inc. - Class A(a)

     22,710          687,205  

Monday.com Ltd.(a)

     2,514          611,304  

Onestream, Inc.(a)

     29,101          621,015  

Rubrik, Inc. - Class A(a)

     10,251          625,106  

ServiceTitan, Inc. - Class A(a)

     3,400          323,374  

Workiva, Inc.(a)

     7,369          559,381  
       

 

 

 
          7,423,547  
       

 

 

 

Technology Hardware, Storage & Peripherals – 1.4%

 

ACV Auctions, Inc. - Class A(a)

     55,218          778,021  
       

 

 

 
           12,144,552  
       

 

 

 

Consumer Discretionary – 13.4%

 

Automobile Components – 1.2%

 

Modine Manufacturing Co.(a) (b)

     8,487          651,377  
       

 

 

 

Broadline Retail – 1.7%

 

Ollie’s Bargain Outlet Holdings, Inc.(a) (b)

     7,908          920,175  
       

 

 

 

Hotels, Restaurants & Leisure – 5.3%

 

Dutch Bros, Inc. - Class A(a)

     10,140          626,044  

Portillo’s, Inc. - Class A(a) (b)

     49,115          583,977  

Rush Street Interactive, Inc.(a)

     60,492          648,474  

Texas Roadhouse, Inc.

     3,654          608,866  

Wingstop, Inc.

     1,872          422,286  
       

 

 

 
          2,889,647  
       

 

 

 

Household Durables – 2.1%

 

Champion Homes, Inc.(a) (b)

     9,540          904,010  

SharkNinja, Inc.(a)

     2,599          216,783  
       

 

 

 
          1,120,793  
       

 

 

 

Specialty Retail – 3.1%

 

Boot Barn Holdings, Inc.(a) (b)

     7,296          783,809  

Five Below, Inc.(a)

     6,457          483,791  

RH(a) (b)

     1,872          438,816  
       

 

 

 
          1,706,416  
       

 

 

 
          7,288,408  
       

 

 

 

 

3


Company    Shares        U.S. $ Value  

Financials – 9.7%

 

Capital Markets – 5.4%

 

Houlihan Lokey, Inc.

     4,263        $ 688,475  

Piper Sandler Cos.

     3,282          812,820  

StepStone Group, Inc. - Class A

     14,173          740,256  

Stifel Financial Corp.

     7,332          691,114  
       

 

 

 
          2,932,665  
       

 

 

 

Financial Services – 2.1%

 

NCR Atleos Corp.(a)

     25,913          683,585  

Shift4 Payments, Inc. - Class A(a) (b)

     5,893          481,517  
       

 

 

 
            1,165,102  
       

 

 

 

Insurance – 2.2%

 

Palomar Holdings, Inc.(a)

     993          136,120  

RLI Corp.

     8,303          666,980  

TWFG, Inc.(a)

     11,947          369,282  
       

 

 

 
          1,172,382  
       

 

 

 
          5,270,149  
       

 

 

 

Consumer Staples – 3.8%

 

Beverages – 1.1%

       

Celsius Holdings, Inc.(a)

     16,434          585,379  
       

 

 

 

Consumer Staples Distribution & Retail – 1.0%

 

Chefs’ Warehouse, Inc. (The)(a) (b)

     10,615          578,093  
       

 

 

 

Personal Care Products – 1.7%

 

BellRing Brands, Inc.(a)

     12,257          912,656  
       

 

 

 
          2,076,128  
       

 

 

 

Materials – 1.8%

 

Chemicals – 1.2%

 

Element Solutions, Inc.

     28,608          646,827  
       

 

 

 

Construction Materials – 0.6%

 

Titan America SA(a)

     24,816          335,512  
       

 

 

 
          982,339  
       

 

 

 

Energy – 0.7%

 

Energy Equipment & Services – 0.6%

 

Flowco Holdings, Inc. - Class A(a)

     7,749          198,762  

TechnipFMC PLC

     4,301          136,299  
       

 

 

 
          335,061  
       

 

 

 

Oil, Gas & Consumable Fuels – 0.1%

 

Permian Resources Corp.

     2,639          36,550  
       

 

 

 
          371,611  
       

 

 

 

Total Common Stocks
(cost $52,606,827)

          53,712,752  
       

 

 

 

 

4


Company    Shares        U.S. $ Value  

SHORT-TERM INVESTMENTS – 1.5%

 

Investment Companies – 1.5%

       

AB Fixed Income Shares, Inc. - Government Money Market Portfolio - Class AB, 4.20%(c) (d) (e)
(cost $818,850)

     818,850        $ 818,850  
       

 

 

 

Total Investments Before Security Lending Collateral for Securities Loaned – 100.1%
(cost $53,425,677)

          54,531,602  
       

 

 

 

INVESTMENTS OF CASH COLLATERAL FOR SECURITIES LOANED – 1.4%

 

Investment Companies – 1.4%

 

AB Fixed Income Shares, Inc. - Government Money Market Portfolio - Class AB, 4.20%(c) (d) (e)
(cost $734,613)

     734,613          734,613  
       

 

 

 

Total Investments – 101.5%
(cost $54,160,290)(f)

          55,266,215  

Other assets less liabilities – (1.5)%

          (799,423
       

 

 

 

Net Assets – 100.0%

        $  54,466,792  
       

 

 

 

 

(a)

Non-income producing security.

(b)

Represents entire or partial securities out on loan.

(c)

The rate shown represents the 7-day yield as of period end.

(d)

Affiliated investments.

(e)

To obtain a copy of the fund’s shareholder report, please go to the Securities and Exchange Commission’s website at www.sec.gov. Additionally, shareholder reports for AB funds can be obtained by calling AB at (800) 227-4618.

(f)

As of March 31, 2025, the cost basis of investment securities owned was substantially identical for both book and tax purposes. Gross unrealized appreciation of investments was $7,896,581 and gross unrealized depreciation of investments was $(6,790,656), resulting in net unrealized appreciation of $1,105,925.

 

Please note: The sector classifications presented herein are based on the Global Industry Classification Standard (GICS) which was developed by Morgan Stanley Capital International and Standard & Poor’s. The components are divided into sector, industry group, and industry sub-indices as classified by the GICS for each of the market capitalization indices in the broad market.

Glossary:

ADR – American Depositary Receipt

 

5


AB Variable Products Series Fund, Inc.

AB Small Cap Growth Portfolio

March 31, 2025 (unaudited)

In accordance with U.S. GAAP regarding fair value measurements, fair value is defined as the price that the Portfolio would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a framework for measuring fair value, and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability (including those valued based on their market values). Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Portfolio. Unobservable inputs reflect the Portfolio’s own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-tier hierarchy of inputs is summarized below.

 

   

Level 1 - quoted prices in active markets for identical investments

   

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

   

Level 3 - significant unobservable inputs (including the Portfolio’s own assumptions in determining the fair value of investments)

Where readily available market prices or relevant bid prices are not available for certain equity investments, such investments may be valued based on similar publicly traded investments, movements in relevant indices since last available prices or based upon underlying company fundamentals and comparable company data (such as multiples to earnings or other multiples to equity). Where an investment is valued using an observable input, by pricing vendors, such as another publicly traded security, the investment will be classified as Level 2. If management determines that an adjustment is appropriate based on restrictions on resale, illiquidity or uncertainty, and such adjustment is a significant component of the valuation, the investment will be classified as Level 3. An investment will also be classified as Level 3 where management uses company fundamentals and other significant inputs to determine the valuation.

The following table summarizes the valuation of the Portfolio’s investments by the above fair value hierarchy levels as of March 31, 2025:

 

Investments in Securities:

   Level 1      Level 2      Level 3      Total  
Assets:            
Common Stocks(a)    $ 53,712,752      $      $      $ 53,712,752  
Short-Term Investments      818,850                      818,850  
Investments of Cash Collateral for Securities Loaned in Affiliated Money Market Fund      734,613                      734,613  
  

 

 

    

 

 

    

 

 

    

 

 

 
Total Investments in Securities      55,266,215                      55,266,215  
Other Financial Instruments(b)                            
  

 

 

    

 

 

    

 

 

    

 

 

 
Total    $  55,266,215      $     —      $     —      $  55,266,215  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

See Portfolio of Investments for sector classifications.

 

(b) 

Other financial instruments include derivative instruments, such as futures, forwards and swaps. Derivative instruments are valued at the unrealized appreciation (depreciation) on the instrument. Other financial instruments may also include swaps with upfront premiums, written options and written swaptions which are valued at market value.

 

6


A summary of the Portfolio’s transactions in AB mutual funds for the three months ended March 31, 2025 is as follows:

 

Portfolio   

Market Value

12/31/2024
(000)

     Purchases
at Cost
(000)
     Sales
Proceeds
(000)
    

Market Value

03/31/2025

(000)

     Dividend
Income
(000)
 
AB Government Money Market Portfolio    $ 683      $ 8,406      $ 8,270      $ 819      $ 11  
AB Government Money Market Portfolio*      1,211        8,317        8,793        735        13  
Total    $  1,894      $  16,723      $  17,063      $  1,554      $  24  

 

*

Investments of cash collateral for securities lending transactions.

 

7